1. GlaxoSmithKline Consumer Healthcare Limited
Financial Results
Quarter 4 - FY & Financial Year

2. Quarter Highlights Revenue increased by 9% (Volume Growth 6.5%)
Growth is across portfolio and channels.
Rural growth continues to accelerate in double digit.
PBT increased by 34%
Continued investment behind brands: 13% vs LY to fund innovation & drive Horlicks campaign
Drive HFD Consumption
Brand building initiatives, continue to strengthen / expand the initiatives:
The “Better Protein” launch campaign emphasized on Triple Blend Protein story to establish product superiority.
Digital campaign for Women Horlicks covering Real Stories of Strength of Successful women.
BOOSTCAMP, a platform for training young kids for varied sports, signifying more” Energy”, “stamina” and “Winning” among kids.
Sachet volume continue to grow high double digit, led by visible distribution & strong on-air support.

3. Financial Performance: Q4 FY18-19
Net Sales Q4 FY 18-19

4. Financial Performance: Financial Year 18-19
* Comparable revenue growth of 12%
Net Sales FY 18-19

5. Horlicks continues to be at first position in HFD category
Market Share
Brand
Volume
Value
Horlicks 49.5%
Horlicks 42.9%
Boost 14.0 %
Boost 10.7 %
Horlicks continues to be at first position in HFD category
Source – AC Nielsen; Market Share MAT Mar 19

6. Thank You